<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-CPMFDWT3</identifier><date>2020</date><creator>Bratkovič, Tomaž</creator><creator>Lunder, Mojca</creator><creator>Štrukelj, Borut</creator><relation>documents/doc/C/URN_NBN_SI_doc-CPMFDWT3_001.pdf</relation><relation>documents/doc/C/URN_NBN_SI_doc-CPMFDWT3_001.txt</relation><format format_type="issue">2</format><format format_type="volume">71</format><format format_type="type">article</format><format format_type="extent">str. 141-147</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">21009411</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-CPMFDWT3</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">covid-19</subject><subject language_type_id="slv">NSAR</subject><subject language_type_id="slv">obrazne maske</subject><subject language_type_id="slv">Pandemije</subject><subject language_type_id="slv">Prehranska dopolnila</subject><subject language_type_id="slv">razkužila</subject><title>Podporno zdravljenje covid-19 in preprečevanje okužbe s SARS-CoV-2</title><title>Supportive therapy for covid-19 and preventing SARS-CoV-2 infection</title></Record>